Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2V1 pseudogene 9 (UBE2V1P9) is a non-functional genomic locus highly homologous to the protein-coding UBE2V1 gene, which belongs to the E2 ubiquitin-conjugating enzyme family[1][5]. Pseudogenes do not encode functional proteins and generally do not participate directly in biological pathways, drug targeting, or disease mechanisms. Multiple pseudogenes for UBE2V1 exist in the human genome, including this member, which is mainly of interest for comparative genomics and evolutionary studies rather than as a biological or therapeutic target[5]. The functional UBE2V1 gene is involved in K63-linked polyubiquitination, protein aggregation, and has proto-oncogenic activity[3][1][5]. However, pseudogenes, including UBE2V1P9, are not direct contributors to these functions. Queries involving UBE2V1P9 as a therapeutic target are incorrect or biologically irrelevant; focus should be on the functional protein if drug- or disease-oriented details are needed. If you require structured or mechanistic data on the active enzyme, refer to “Ubiquitin-conjugating enzyme E2 variant 1 (UBE2V1)”, not the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin-conjugating enzyme E2 variant 1 pseudogene 9 (UBE2V1P9).